SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-098238
Filing Date
2023-12-22
Accepted
2023-12-22 16:30:10
Documents
13
Period of Report
2023-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190504-8k_aditxtinc.htm   iXBRL 8-K 28678
2 FORM OF CONSULTING AGREEMENT ea190504ex10-1_aditxtinc.htm EX-10.1 22848
  Complete submission text file 0001213900-23-098238.txt   233741

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20231219.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20231219_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20231219_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT ea190504-8k_aditxtinc_htm.xml XML 3393
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 231510230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)